Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EnRoute+ Study: Micrometastases in Stage I-II Colon Cancer
NCT01097265Phase 3Unknown
- Sponsor
- Jeroen Bosch Hospital
- Start
- Jul 2010
- Primary completion
- Jan 2015
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine, oxaliplatin in colon cancer, sponsored by Jeroen Bosch Hospital. Status: unknown.
02
Drugs
capecitabineoxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT01097265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01097265.